Submit Deck
Become LP
Location:
65 East 55th Street
New York, NY 10022
USA
Investor Type:
Sector Focus:
Round Preference:
Investment Region:
Download StockFan App Ad
Stock market data, news and community, all integrated.
Features include real time stock quotes, interactive charts, technical signals, institutional & insider ownerships, stock screener, ETF rankings, SEC filings, press releases, videos, earnings calendar, social media posts, group chats.
About
Luma Group is an investment firm focused on the greatest breakthrough scientific discoveries that leverage advanced computation and AI. Luma invests in discovering, developing and commercializing potentially high-caliber technologies to seek to improve human health and longevity. We aim to focus on the following areas in biotech: next generation therapeutics, AI/ML enabled drug discovery platforms, AI/ML technologies transforming early disease detection and patient care, and devices and tools with advanced data capture mechanisms and analysis capabilities. Luma is led by Partners Josh Fink, Dr. Themasap Khan, PhD, and Dr. Jamie Kasuboski, PhD, each with over a decade of biotech investing and operational experience. The Luma team is backed by an advisory network that includes former C-suite executives at Fortune 500 companies, seasoned executives with strong track records in building biotech companies and healthcare leaders. We seek to leverage the Firm’s strengths to invest in companies that have strong intellectual property protections, and which address large unmet medical needs. Our mission is to work closely with portfolio companies to help them focus on addressing untapped markets and generating shareholder value.
Recent Investments